Uractiv Alkasolv, 30 sachets, Fiterman PharmaProperties: Food supplement with the effect of maintaining the hydroelectrolytic balance and correcting the urinary pH in people prone to kidney stones Uractiv Alkasolv is an effective long-term solution for preventing the occurrence of kidney stones by controlling the elimination of calcium in the urine and the balance of the urinary pH at a value that prevents the precipitation of calcium salts from the urine in the form of stones. Uractiv Alkasolv, sachets do not contain sodium (contains potassium citrate) and therefore can be safely administered to patients with hypertension or heart rhythm disorders. Uractiv Alkasolv sachets contain sucralose, a sweetener with zero calories and therefore can be administered safely to diabetic patients. Uractiv Alkasolv can be administered to pregnant women, on the recommendation of the specialist doctor. Natural orange taste.Indications: For people with a tendency to form urinary stones For people who have followed a lithotripsy procedure Recommendations: - Keep out of the reach and sight of children. - To be kept at temperatures below 25°C, in the original packaging. - Do not exceed recommended dose for daily consumption. - Food supplements do not replace a varied and balanced diet and a healthy lifestyle. Action/Effects: Magnesium The additional intake of magnesium leads to balancing the ratio between magnesium and calcium in the urine, in favor of magnesium. In people with a tendency to urolithiasis, there is an excess of calcium elimination through the urine, which is deposited in the form of insoluble calcium salts and which will later form stones. Additional intake of magnesium reduces the elimination of calcium in the urine and the formation of calcium salts at this level. Magnesium salts eliminated through urine are soluble and do not form stones Potassium citrate Alkaline citrates (potassium and sodium) contribute to reducing the formation of urinary calculi by alkalinizing the urine (in an acidic urine environment, calcium salts form precipitates that will grow in size forming stones; in an alkaline environment, calcium salts do not precipitate and are prevented from forming solid agglomerations). Vitamin B6 (pyridoxine) Vitamin B6 increases the bioavailability of magnesium and maintains its optimal concentration in the cell. Vitamin B6 contributes to the normal metabolism of cysteine, an amino acid involved in the formation of kidney stones. Composition: Uractiv Alkasolv, sachets contain 20 mEq potassium citrate, 11 mEq magnesium citrate, 25 mg vitamin B6 Administration method: 1 sachet per day preferably in 2 doses, morning and evening. The content of each sachet is dissolved in 150-300 ml of water. At the doctors recommendation and depending on the urinary pH after a trial period, the dose can be adjusted. Presentation: 30 envelopes